5 Einträge gefunden

1. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer

   1. Marx, Andreas
   2. Koopmann, Lena
   3. Höflmayer, Doris
   4. Büscheck, Franziska
   5. Hube-Magg, Claudia
   6. Steurer, Stefan
   7. Eichenauer, Till

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

   1. Kind, Simon
   2. Büscheck, Franziska
   3. Höflmayer, Doris
   4. Hube-Magg, Claudia
   5. Kluth, Martina
   6. Tsourlakis, Maria Christina
   7. Steurer, Stefan

   2020 - Forschungsinformationssystem des UKE
3. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

   1. Höflmayer, Doris
   2. Steinhoff, Amélie
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Burandt, Eike
   7. Tsourlakis, Maria Christina

   2020 - Forschungsinformationssystem des UKE
4. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

   1. Minner, Sarah
   2. Lutz, Jannes
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Höflmayer, Doris
   7. Burandt, Eike

   2019 - Forschungsinformationssystem des UKE
5. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability, and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

   1. Wilczak, Waldemar
   2. Rashed, Semin
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Büscheck, Franziska
   7. Clauditz, Till Sebastian

   2017 - Forschungsinformationssystem des UKE